These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oral progestins and regression of carcinoma in situ and cervical dysplasia. A cytologic evaluation. Ayre JE, Reyner FC, Fagundes WB, Leguerrier JM. Obstet Gynecol; 1969 Oct 15; 34(4):545-60. PubMed ID: 5822680 [No Abstract] [Full Text] [Related]
6. [Therapy of diffuse dyshormonal hyperplasia of the breasts]. Sidorenko LN, Shal'neva TS. Vopr Onkol; 1973 Oct 15; 19(11):72-6. PubMed ID: 4785976 [No Abstract] [Full Text] [Related]
8. [Effect of infecundin on the hypothalamo-hypophyseal-ovarian system in the treatment of dysfunctional uterine hemorrhages]. Akker LV. Akush Ginekol (Mosk); 1977 Feb 15; (2):20-3. PubMed ID: 900367 [No Abstract] [Full Text] [Related]
9. [Pathogenetic conditioning of the therapeutic effect of infecundin]. Kozhin AA. Akush Ginekol (Mosk); 1978 Aug 15; (8):40-3. PubMed ID: 568394 [No Abstract] [Full Text] [Related]
17. [Clinical and morphological parallels in the treatment of dysfunctional uterine hemorrhages with Infecundin]. Tikhomirov BM. Akush Ginekol (Mosk); 1972 Apr 15; 48(4):64-5. PubMed ID: 4639209 [No Abstract] [Full Text] [Related]
18. [Blood coagulation system indices in women with dysfunctional hemorrhage during treatment with infecundin]. Manuilova IA, Aronovich AS, Tumanova AE. Sov Med; 1971 Jan 15; 34(1):27-30. PubMed ID: 5580234 [No Abstract] [Full Text] [Related]